GSK oncology is committed to driving toward
*Includes an asset and trials in collaboration and license alliance with iTeos Therapeutics and assets and trials in-license or from other partnership with third parties.
*Includes an asset and trials in collaboration and license alliance with iTeos Therapeutics and assets and trials in-license or from other partnership with third parties.